ライフサイエンスコーパス: guanosine 5'-monophosphate

1 e or guanylate, inosine 5'-monophosphate and guanosine-5'-monophosphate).

2 is independent of global elevation of cyclic guanosine 5'-monophosphate.

3 Evidence is presented for complexation of guanosine 5'-monophosphate 2-methylimidazolide (2-MeImpG

4 dazolide derivatives of nucleotides, such as guanosine 5'-monophosphate 2-methylimidazolide (2-MeImpG

5 olycytidylic acid-directed polymerization of guanosine 5'-monophosphate 2-methylimidazolide (2-MeImpG

6 the concentration of the activated monomer, guanosine 5'-monophosphate 2-methylimidazolide, 2-MeImpG

7 of the enzymes involved in ppGpp, pppGpp and guanosine 5'-monophosphate 3'-diphosphate (pGpp) (collec

8 for potential existence of a third alarmone, guanosine-5'-monophosphate-3'-diphosphate (pGpp), with l

9 These derivatives are guanosine 5'-monophosphate (5'GMP), guanosine 5'-monopho

10 -methionine (l-Met), l-cysteine (l-Cys), and guanosine-5'-monophosphate (5'-GMP) decreases in the ord

11 s potentiation by 5'-ribonucleotides such as guanosine-5'-monophosphate and inosine 5'-monophosphate,

12 where TMA is [(CH(3))(4)N](+) and 5'-GMP is guanosine 5'-monophosphate, and K(2)(5'-GMP), containing

13 '-monophosphate, thymidine-5'-monophosphate, guanosine-5'-monophosphate, and cytidine-5'-monophosphat

14 ells to H(2)S increases intracellular cyclic guanosine 5'-monophosphate (cGMP) in a NO-dependent mann

15 Cyclic guanosine 5'-monophosphate (cGMP) phosphodiesterase (PDE

16 to synthesize a N-acetyl-(2-aminofluorenyl)-guanosine 5'-monophosphate (dGpAAF) adduct, which was su

17 nd is responsible for the phosphorylation of guanosine 5'-monophosphate (GMP) and dGMP to guanosine 5

18 The crystal structures of the guanosine 5'-monophosphate (GMP) and inosine 5'-monophos

19 arkbound in a fashion similar to that of the guanosine 5'-monophosphate (GMP) and inosine 5'-monophos

20 osphate (ADP) and guanosine conformations of guanosine 5'-monophosphate (GMP) bound to wild type and

21 the hypothesis that nitric oxide (NO) cyclic guanosine 5'-monophosphate (GMP) signaling is deficient

22 Specifically, a known competitive inhibitor, guanosine 5'-monophosphate (GMP), and a synthetic, trans

23 hway is redundant and contains two routes to guanosine-5'-monophosphate (GMP) formation: conversion f

24 inone (H2Q), N-acetyl-tyrosine (N-Ac-Tyr) or guanosine-5'-monophosphate (GMP) was investigated at var

25 del for SurE bound to a potential substrate, guanosine-5'-monophosphate (GMP).

26 onophosphate 2-methylimidazolide (2-MeImpG), guanosine 5'-monophosphate imidazolide (ImpG), and adeno

27 ives are guanosine 5'-monophosphate (5'GMP), guanosine 5'-monophosphate imidazolide (ImpG), and guano

28 In mice, exposure to CS reduced sGC, cyclic guanosine 5'-monophosphate levels, and protein kinase G

29 ine 5'-monophosphate imidazolide (ImpG), and guanosine 5'-monophosphate morpholidate (morpG).

30 ility of G-quartet stacks formed by disodium guanosine 5'-monophosphate (Na25'-GMP).

31 The free energy of binding guanosine 5'-monophosphate (pG) at 30 degrees C is simil

32 lla pneumoniae BlrP1, a light-activated c-di-guanosine 5'-monophosphate phosphodiesterase which consi

33 The Leishmania guanosine 5'-monophosphate reductase (GMPR) and inosine

34 Guanosine 5'-monophosphate reductase (GMPR) is involved

35 Guanosine-5'-monophosphate reductase (GMPR) catalyzes th

36 f either MLL exon 7 or exon 8 with the GMPS (GUANOSINE 5'-MONOPHOSPHATE SYNTHETASE) gene from chromos

37 its platelet activation by generating cyclic guanosine 5'-monophosphate, which is metabolized by phos

38 itro in reactions supplemented with biotinyl-guanosine 5'-monophosphate, which led to the specific ad